NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Abionic SA

Abionic SA

Private
EpalingesHealthcare & Life Scienceshttps://abionic.com/

Last Round

Series C

Mar 28, 2018

Total Funding Raised

$28.97M

Company Overview

Abionic SA is a medical technology company that develops and manufactures ultra-rapid in vitro diagnostic solutions using proprietary nanofluidic technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC testingnanofluidic technologyin vitro diagnosticsIVDdiagnostic platformrazor-and-blade modelclinical diagnosticsimmunoassaymedical deviceacute care diagnosticsdiagnostic cartridgesbedside testingrapid testingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abionic SA Comparables

Compare Abionic SA with similar companies based on industry and business-model similarity.

Abionic SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoDx
84%
Novus Diagnostics
84%
SphingoTec
82%

Abionic SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 28, 2018
Series BOct 14, 2014
Series AApr 26, 2012
AcceleratorOct 1, 2010

Key People

Founding team and executive leadership

Iwan Märki

CTO and Co-Founder

Founding Team

Patrick Pestalozzi

Chief Executive Officer

Executive Team

Abionic SA Investors

Notable investors and investment history

Abionic SA investors
InvestorRounds
Verve VenturesSeries C
Business Angels SwitzerlandSeries A
Immo DumasSeries C
Venture KickAccelerator
PolyTech VenturesSeries A
Zurcher KantonalbankSeries C
Drexel Morgan & Co.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 214% MoM, reaching 2.1K.

  • Mar 28, 2018

    $21M round led by Pierangelo Bottinelli.

Abionic SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Abionic SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abionic SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges
Employee Range31
Year Founded2010
Last FundingMar 28, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.